GT Biopharma Inc. (GTBP) Net Income by Year
GT Biopharma Inc. reported a net loss of $28.4M in fiscal year 2025. This represents a decrease of 115.4% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters GT Biopharma Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
GTBP Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
GTBP Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More GT Biopharma Inc. financials
Frequently Asked Questions
What was GT Biopharma Inc.'s net income in fiscal year 2025?
GT Biopharma Inc. reported a net loss of $28.4M in fiscal year 2025.
How fast is GT Biopharma Inc.'s net income growing?
GT Biopharma Inc. (GTBP) net income fell by 115.4% year over year, from -$13.2M to -$28.4M in fiscal year 2025.
What was GT Biopharma Inc.'s net income in the most recent quarter?
GT Biopharma Inc. (GTBP) reported -$4.5M in net income in Q2 2026. This represents an increase of 85.0% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what GT Biopharma Inc. (GTBP) reported on that line in every period on record.